We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+23.21%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$27.1B
AUM Growth
+$4.43B
Cap. Flow
-$86.6M
Cap. Flow %
-0.32%
Top 10 Hldgs %
21.67%
Holding
2,442
New
109
Increased
1,083
Reduced
1,137
Closed
107

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$40M
2
AGN
Allergan plc
AGN
+$32.5M
3
RTN
Raytheon Company
RTN
+$26M
4
PSA icon
Public Storage
PSA
+$21M
5
ALL icon
Allstate
ALL
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 24.66%
2 Healthcare 14.4%
3 Financials 13.15%
4 Consumer Discretionary 10.5%
5 Communication Services 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DORM icon
1576
Dorman Products
DORM
$3.98B
$720K ﹤0.01%
10,739
-745
-6% -$47.9K
NTNX icon
1577
Nutanix
NTNX
$16B
$720K ﹤0.01%
30,380
+7,151
+31% +$148K
TARO
1578
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$719K ﹤0.01%
10,807
-3,405
-24% -$228K
RHP icon
1579
Ryman Hospitality Properties
RHP
$8.43B
$718K ﹤0.01%
20,739
+2,897
+16% +$96.2K
MAIN icon
1580
Main Street Capital
MAIN
$5.06B
$716K ﹤0.01%
22,986
+2,536
+12% +$71.5K
SKX
1581
DELISTED
Skechers
SKX
$716K ﹤0.01%
22,817
-9,982
-30% -$286K
OXM icon
1582
Oxford Industries
OXM
$566M
$715K ﹤0.01%
16,254
+7,709
+90% +$321K
UVV icon
1583
Universal Corp
UVV
$1.31B
$713K ﹤0.01%
16,766
-8,121
-33% -$357K
KAMN
1584
DELISTED
Kaman Corp
KAMN
$710K ﹤0.01%
17,064
+6,333
+59% +$245K
HL icon
1585
Hecla Mining
HL
$9.47B
$708K ﹤0.01%
216,408
-17,308
-7% -$47.8K
BPMC
1586
DELISTED
Blueprint Medicines
BPMC
$706K ﹤0.01%
9,055
+1,431
+19% +$96.8K
BVN icon
1587
Compañía de Minas Buenaventura
BVN
$7.69B
$706K ﹤0.01%
77,214
+27,744
+56% +$224K
ADT icon
1588
ADT
ADT
$5.6B
$705K ﹤0.01%
88,366
+29,466
+50% +$191K
ACCO icon
1589
Acco Brands
ACCO
$389M
$704K ﹤0.01%
99,178
-5,216
-5% -$32.4K
FOLD
1590
DELISTED
Amicus Therapeutics
FOLD
$704K ﹤0.01%
46,664
+5,138
+12% +$62.6K
CHDN icon
1591
Churchill Downs
CHDN
$5.88B
$703K ﹤0.01%
10,566
+2,558
+32% +$146K
NVCR icon
1592
NovoCure
NVCR
$1.73B
$701K ﹤0.01%
11,819
-3,418
-22% -$225K
GIII icon
1593
G-III Apparel Group
GIII
$1.54B
$699K ﹤0.01%
52,603
+24,028
+84% +$265K
SUPN icon
1594
Supernus Pharmaceuticals
SUPN
$2.59B
$698K ﹤0.01%
29,386
+2,710
+10% +$59.9K
RETA
1595
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$697K ﹤0.01%
4,469
+578
+15% +$87.9K
TRTN
1596
DELISTED
Triton International Limited
TRTN
$695K ﹤0.01%
22,997
+1,022
+5% +$30.4K
NPO icon
1597
Enpro
NPO
$6.63B
$693K ﹤0.01%
14,054
+1,588
+13% +$70.2K
TTEC icon
1598
TTEC Holdings
TTEC
$121M
$691K ﹤0.01%
14,843
+610
+4% +$24.3K
IMOS
1599
ChipMOS TECHNOLOGIES
IMOS
$1.65B
$690K ﹤0.01%
30,448
+2,458
+9% +$50.4K
ARNA
1600
DELISTED
Arena Pharmaceuticals Inc
ARNA
$690K ﹤0.01%
10,959
+329
+3% +$18.1K

Similar funds

Aperio Group's Q2 2020 Portfolio in Review

As of Q2 2020, Aperio Group held 2,442 positions worth $27.1B, up 20% from $22.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q2 2020 filing shows 109 new, 1,083 increased, 1,137 reduced and 107 closed positions. Its largest new stake was Arconic Corporation: 1,326,595 shares worth $18.5M. The largest sale was AT&T, an estimated $40M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Aperio Group's largest Q2 2020 buy was Arconic Corporation: 1,326,595 shares worth $18.5M.
  • Aperio Group added most to Amazon in Q2 2020, an estimated $35.6M increase.
  • Aperio Group's biggest Q2 2020 reduction was AT&T, cutting an estimated $40M.
  • Aperio Group fully exited Allergan plc in Q2 2020, selling an estimated $32.5M.
  • Aperio Group's ten largest holdings make up 22% of its $27.1B portfolio in Q2 2020.
  • Aperio Group opened 109 new positions and closed 107 in Q2 2020.
  • Aperio Group's portfolio value rose 20% quarter-over-quarter to $27.1B.

Based on Aperio Group's 13F filing for Q2 2020, filed 13 Aug 2020.